Progress in the clinical research of gastric cancer

WANG Jiemin,LIN Sanren

DOI: https://doi.org/10.3969/j.issn.1006-5709.2012.01.002

2012-01-01

Abstract:Dysregulation and polymorphism of the related genes play important roles in etiopathogenesis of gastric cancer.Genetic mutations and over-expression of human epidermal growth factor receptor 2(HER2) and vascular endothelial growth factor(VEGF) and abnormal activation of downstream signal transduction pathway have significant correlations with the genesis and metastasis of gastric cancer,which have been used as target spots of molecular target therapy to treat gastric cancer.There is no doubt that gastric cancer is closely related to Helicobacter pylori(H.pylori).Relevant virulence factors of H.pylori include cytotoxin-associated gene A(CagA),vacuolating cytotoxin A(VacA) and outer membrane protein(OMP).With the evidence that tumor is essentially a kind of diseases from stem cells,research of stem cells in gastric cancer has became a hot point.Gastric cancer screening is a very effective method for early detection.Recently,some scholars recommended gastric cancer screening using the ABC method(combined measurement of serum pepsinogen and H.pylori antibody) and endoscopy,which made the diagnostic rate of early gastric cancer increased to 78%.Great progress has been achieved in the techniques of digestive endoscopy and pathology biopsy.A diversity of new endoscopic techniques and methods have been widely used clinically.Endoscopic submucosal dissection(ESD) has been widespread accepted as the main approach to treat early gastric cancer with a high resection rate in en bloc greater than 95%.The research of molecular target therapy in gastric cancer has developed rapidly and many related medicines approved to enter clinical trials are promising.